quinazolines has been researched along with an2728 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahluwalia, J; Borok, J; Eichenfield, LF; Udkoff, J; Waldman, A | 1 |
| Beck, L; Borok, J; Eichenfield, LF; Simpson, E; Tom, W; Udkoff, J | 1 |
| Bissonnette, R; Boguniewicz, M; Guttman-Yassky, E; Hanifin, JM; Kilty, I; Purohit, V; Tallman, AM; Wollenberg, A; Zielinski, MA | 1 |
3 review(s) available for quinazolines and an2728
| Article | Year |
|---|---|
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook.
Topics: Anisoles; Anti-Inflammatory Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Atopic; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Phthalic Acids; Quinazolines | 2017 |
Atopic dermatitis: emerging therapies.
Topics: Anisoles; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antipruritics; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dermatitis, Atopic; Dermatologic Agents; Emollients; Humans; Infant; Infant Formula; Interleukin-13; Interleukin-4; Nitriles; Phosphodiesterase 4 Inhibitors; Phthalic Acids; Probiotics; Quinazolines | 2017 |
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition.
Topics: Acetamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Dermatitis, Atopic; Drug Approval; Humans; Immune System; Inflammation; Phosphodiesterase Inhibitors; Phthalic Acids; Pyridines; Quinazolines; Risk; Skin; Thalidomide | 2019 |